Table 7.
SNP | CHR | BP | A0 | A1 | Study | HG | CONTROL | OR | 95% CI | p-value | Het p |
---|---|---|---|---|---|---|---|---|---|---|---|
A1 Freq | A1 Freq | ||||||||||
rs16982345 | chr19 | 18500722 | A | G | SCAN1 | 0.8 | 0.73 | 1.47 | [1.33, 1.63] | 6.81E−15 | – |
HG-IV | 0.83 | 0.75 | 1.63 | [1.35, 1.98] | 2.80E−07 | – | |||||
HG-TPN | 0.82 | 0.74 | 1.61 | [1.01, 2.60] | 4.00E−02 | – | |||||
META | – | – | 1.5 | [1.38, 1.65] | 2.12E−19 | 6.62E−01 | |||||
rs4865234 | chr4 | 58355015 | G | A | SCAN1 | 0.7 | 0.64 | 1.32 | [1.20, 1.43] | 7.95E−10 | – |
HG-IV | 0.72 | 0.66 | 1.43 | [1.16, 1.79] | 9.00E−04 | – | |||||
HG-TPN | 0.75 | 0.63 | 1.82 | [1.20, 2.70] | 2.81E−03 | – | |||||
META | – | – | 1.33 | [1.23, 1.62] | 9.29E−12 | 7.27E−01 |
A1 is the allele associated with increased risk of HG